2 completed, 2 not yet recruiting. 4 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 4 | Completed 2, Not yet recruiting 2 |
Follow Giant Cell Arteritis (GCA): new trials by email Literature Review of Giant Cell Arteritis (GCA) trials Research Report on Giant Cell Arteritis (GCA)
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Aspirin for the Prevention of Ischemic Complications in Giant Cell Arteritis Acetyl Salicylic Acid (ASA), Placebo - Giant Cell Arteritis (GCA), Acute Coronary Syndrome (ACS) | Phase 3 | Not yet recruiting | Centre Integre Universitaire de Sante et Services Sociaux du Nord de l'ile de Montreal | 120 | 2027-10-01 | 2026-10-30 |
| Treatment for Giant Cell Arteritis With Tocilizumab and 8 as Compared to 26 Weeks of Prednisone Prednisone - Giant Cell Arteritis (GCA) | Phase 3 | Not yet recruiting | Insel Gruppe AG, University Hospital Bern | 178 | 2026-07-01 | 2026-05-01 |
| Phase III Study of Efficacy and Safety of Secukinumab Versus Placebo, in Combination With Glucocorticoid Taper Regimen, in Patients With Giant Cell Arteritis (GCA) Secukinumab 300 mg, Placebo, Secukinumab 150 mg - Giant Cell Arteritis (GCA) | Phase 3 | Completed | Novartis Pharmaceuticals | 354 | 2021-10-06 | 2026-03-31 |
| A Study to Evaluate the Safety and Efficacy of Upadacitinib in Participants With Giant Cell Arteritis Upadacitinib, Corticosteroid (CS), Placebo - Giant Cell Arteritis (GCA) | Phase 3 | Completed | AbbVie | 429 | 2019-01-24 | 2026-02-24 |
Giant Cell Arteritis (4) · Acute Coronary Syndrome (1) · Vasculitis (1)
Arteritis (4) · Autoimmune Diseases (4) · Autoimmune Diseases of the Nervous System (4) · Brain Diseases (4) · Cardiovascular Diseases (4) · Central Nervous System Diseases (4) · Cerebrovascular Disorders (4) · Immune System Diseases (4) · Nervous System Diseases (4) · Skin Diseases (4) · Skin Diseases, Vascular (4) · Skin and Connective Tissue Diseases (4) · Vascular Diseases (4) · Vasculitis, Central Nervous System (4) · Vasculitis (3)
Adrenal Cortex Hormones (1) · Prednisone (1) · secukinumab (1) · upadacitinib (1)
AbbVie (1) · Centre Integre Universitaire de Sante et Services Sociaux du Nord de l'ile de Montreal (1) · Insel Gruppe AG, University Hospital Bern (1) · Novartis Pharmaceuticals (1)
Canada (3) · Switzerland (3) · Australia (2) · Austria (2) · Belgium (2) · Czechia (2) · Denmark (2) · France (2) · Germany (2) · Greece (2) · Hungary (2) · Israel (2) · Italy (2) · Norway (2) · Portugal (2)
Jean-Paul Makhzoum, MD (1) · Lisa Christ, Dr. med. (1)
PMID 38840219, PMID 40174237, PMID 42234457
2017 (1), 2023 (1)